Major study aims to predict pain relief in bone cancer patients

NCT ID NCT02356497

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 2500 cancer patients with bone metastases to better understand why some respond to radiation therapy and others do not. Researchers will collect data to build tools that predict pain relief and survival, and to create a platform for testing new treatments. The goal is to improve quality of life and personalize care for patients with bone metastases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better prediction tools for pain relief and survival, and faster testing of new treatments for bone metastases.

What could go wrong

This is an observational study, so it does not test a new treatment directly. The prediction tools may not be accurate enough to change clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone disorder metastatic carcinoma in the bone

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University Medical Center Utrecht

    RECRUITING

    Utrecht, Utrecht, 3508 GA, Netherlands

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••